Earnings Call · Q2 FY2021·2021-08-09

Q2 21EPS -5.26%·Rev n/aQ1 21EPS -5.41%·Rev n/aQ4 20EPS -11.39%·Rev n/aQ3 20EPS +5.88%·Rev n/a⚠ consensus missing

Gossamer Bio, Inc. GOSS

Bryan Giraudo — Chief Financial Officer

Faheem Hasnain — Chairman, Co-Founder and Chief Executive Officer

Richard Aranda — Chief Medical Officer

+1.3%1d on move date+1.4% vs SPY3d+0.8%5d+9.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GOSS calls or request research access.

More GOSS calls Browse calls Request research access